Parkinson's Invest Advisor

Gain Therapeutics Announces Webinar on GT-02287, a Promising Therapy for Parkinson's Disease Sep 26, 2024

Ventyx Biosciences Commences Phase 2a Trial for VTX3232 in Early Parkinson's Disease Patients Sep 6, 2024